RITTERSHAUS Partner Martin Bürmann will chair a session at the European Business Development Conference held on September 25th, 2019 at the DKFZ German Cancer Center in Heidelberg on “How is the pharma business model changing? What are the implications?”.
The European Business Development Conference is a special networking event for decision makers in the pharmaceutical, biotech and investment sectors with approx. 150 attendees.
Martin has been advising biotech companies and their investors since 1999. He has a deep knowledge of the biotech industry and has been working in the supervisory board of several biotech firm for many years.